
An international company is establishing itself in Canada and has chosen Pomerleau as its partner to manage the construction of its industrial center. The project includes the deconstruction and reconstruction of the interior of the existing building using specific pharmaceutical processes, as well as the construction of a new industrial center, an extension of the existing building. This new construction will increase production capacity and meet growing market needs. The industrial center will process blood plasma to produce medications for people with specific albumin or immunoglobulin needs.
This project is strategic for the Canadian pharmaceutical sector. It will help strengthen the country's self-sufficiency in the production of vital medicines, while improving the quality of life for many people. It will generate jobs, stimulate the local economy, and strengthen Canada's position in the field of biotechnology, while meeting high standards of sustainability and energy efficiency.
This type of industrial project requires adaptability and sensitivity to change. This requires a methodical and rigorous organization to ensure that each modification is properly reported and integrated without impacting the project. Pomerleau thus ensures that it always maintains the client's budget and schedule while adapting to requested changes. Everything is documented and clearly identified for the client. Our team has, of course, been made aware of and trained in GMP (Good Manufacturing Practices) prior to construction, in order to always be as close as possible to our client's needs and challenges.
The challenges encountered are often complex, as they directly impact pharmaceutical processes and require the coordination and involvement of highly specialized engineers and subcontractors. This collaborative approach is essential to effectively resolve any challenges and keep the project on track.
Since the drugs produced are intended to be injected, the entire construction process must meet strict safety and quality standards. Strict controls are applied at every stage to ensure compliance with the highest pharmaceutical standards.
The project is LEED certified, guaranteeing high standards of sustainability and energy efficiency. In addition to this certification, the Pomerleau team implemented ambitious site management, recycling more than 80% of waste and reducing fossil fuel requirements through specific measures, such as the use of white paint on the roof and 100% electric heating, thereby reducing CO2eq emissions by more than 70%.
The entire project was modeled in 3D to coordinate plans and facilitate the coordination of work and teams on site. This modeling allows for visualization of the project before construction and ensures that all technical aspects are properly integrated.
Virtual reality goggles were used to show the client the project before construction, allowing them to visualize the building and make adjustments before work began.
In addition, drones and 3D scanning were used for various purposes, including project progress monitoring and quality assurance checks. Pomerleau thus provided our client with documented and consistent quality monitoring, adhering to plans and specifications as well as the highest pharmaceutical construction standards.
Throughout our collaboration, Pomerleau has consistently demonstrated professionalism, efficiency, and a high level of quality in its work. What sets Pomerleau apart is its commitment to quality, attention to detail, and effective communication throughout the various phases of the project. Its ability to proactively resolve issues and adapt to changing project needs has made it a reliable and valuable partner.